Picture of Nang Kuang Pharmaceutical Co logo

1752 Nang Kuang Pharmaceutical Co Cashflow Statement

0.000.00%
tw flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Annual cashflow statement for Nang Kuang Pharmaceutical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line224235411214303
Depreciation
Amortisation
Non-Cash Items15.626.9-75.914223.4
Unusual Items
Other Non-Cash Items
Changes in Working Capital-273115-142-195-43.1
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities151557369343466
Capital Expenditures-73.2-160-94.2-301-526
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-38.8-132-15.7-28.8154
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-112-291-110-330-372
Financing Cash Flow Items50030.30.056-0.268
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-164-114-275-35.8-171
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-125151-15.9-22.7-76.9